12/4
09:08 am
kytx
Kyverna Therapeutics (NASDAQ:KYTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Kyverna Therapeutics (NASDAQ:KYTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
11/25
01:53 pm
kytx
Kyverna Therapeutics (NASDAQ:KYTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Medium
Report
Kyverna Therapeutics (NASDAQ:KYTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
11/13
12:28 pm
kytx
Kyverna Therapeutics GAAP EPS of -$0.85 misses by $0.04 [Seeking Alpha]
Medium
Report
Kyverna Therapeutics GAAP EPS of -$0.85 misses by $0.04 [Seeking Alpha]
11/12
07:10 pm
kytx
Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/12
04:05 pm
kytx
Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Medium
Report
Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
11/12
01:27 pm
kytx
Kyverna Therapeutics (NASDAQ:KYTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Kyverna Therapeutics (NASDAQ:KYTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
11/10
08:00 am
kytx
Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference
Low
Report
Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference
11/3
08:00 am
kytx
Kyverna Therapeutics Secures up to $150 Million in Non-Dilutive Financing from Oxford Finance
Medium
Report
Kyverna Therapeutics Secures up to $150 Million in Non-Dilutive Financing from Oxford Finance
11/12/2025
04:05 pm
kytx
kyverna therapeutics, inc.
BEAT
Report
-4.7%
kyverna therapeutics, inc.
8/12/2025
04:02 pm
kytx
kyverna therapeutics, inc.
BEAT
Report
14.9%
kyverna therapeutics, inc.
5/13/2025
04:02 pm
kytx
kyverna therapeutics, inc.
BEAT
Report
-7.3%
kyverna therapeutics, inc.
11/17
03:41 pm
kytx
Form SCHEDULE 13G Kyverna Therapeutics, Filed by: GordonMD Global Investments LP
Low
Report
Form SCHEDULE 13G Kyverna Therapeutics, Filed by: GordonMD Global Investments LP
11/12
04:12 pm
kytx
Form 10-Q Kyverna Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Kyverna Therapeutics, For: Sep 30
11/12
04:10 pm
kytx
Form 8-K Kyverna Therapeutics, For: Nov 12
Medium
Report
Form 8-K Kyverna Therapeutics, For: Nov 12
11/3
08:01 am
kytx
Form 8-K Kyverna Therapeutics, For: Nov 02
Medium
Report
Form 8-K Kyverna Therapeutics, For: Nov 02
10/29
08:00 am
kytx
Form 8-K Kyverna Therapeutics, For: Oct 29
Medium
Report
Form 8-K Kyverna Therapeutics, For: Oct 29
10/29
06:32 am
kytx
Form 8-K Kyverna Therapeutics, For: Oct 29
High
Report
Form 8-K Kyverna Therapeutics, For: Oct 29
9/25
04:06 pm
kytx
Form 8-K Kyverna Therapeutics, For: Sep 19
Medium
Report
Form 8-K Kyverna Therapeutics, For: Sep 19
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register